A few days ago, price of tall excessive of willow drug stock buys 10 thousand pharmacy to be superintended ask ask. Domain of officinal production research and development is short in although explanation of willow drug stock is bought this,can making up for a company board, but the expert raises doubt, think to buy a likelihood this to trade about couplet problem.
To this, reporter of Chinese net finance and economics calls Dong Bi of willow drug stock, relevant controller expresses, concerned correlation trades the specification of the respect had had relevant exposure in announcement, company and company accuse to control person, hold a partner, actually fair the partner of 5% above share and company Dong Gao inspect and trade the silver of copartner short for Zhejiang Province of Liu Yaotian source believes the other side and, plain money negotiable securities, the direct or indirect copartner that day source collects a He Chuangjie to invest / between partner all nonexistent any correlation concern or other benefit concerns. Willow drug stock represents, the company serves as trade the limited partner of the other side, according to source of willow medicine day " partnership agreement " agreement, company according to allocate order to enjoy fixed get one's own back. Trade this won't current to the company outstanding achievement produces an effect.
Recently, announcement of willow drug stock says, plan to buy in all business of partnership of management of investment of source of day of medicine of black town willow (limited partnership) 10 thousand pharmacy of hold 60% equity, trade amount is 716 million yuan. Although did not form major asset to recombine,buy this, still drew the market and the attention of superintendency layer. The relevant item that hands in place to send stock of drug of case requirement willow to be bought to this undertakes check and complementing announcing.
On October 16 evening, willow drug stock says in reply announcement, domain of officinal production research and development is short in buying 10 thousand pharmacy to be able to make up for a company board. "Willow drug stock is to let partnership company buy 10 thousand pharmacy first, buy from partnership company again next, this may have some of problem among them. " Shi Lichen of advisory author of medicine of Beijing vessel official expresses, january 2017, the appraise worth amount of 100% equity is 10 thousand pharmacy 700 million yuan, through a year of many time, appraise is worth growth to reach 1.26 billion yuan, excessive price is too high.
The data shows, willow drug stock is an omnibus medicine appears on the market enterprise, show level advocate business Wu is in medicine is current domain. Willow drug stock represents in reply announcement, although Chinese traditional medicine produces business to take a company proportion of current business income is lesser, but buy this after finishing, the company will strengthen a company to be in further industrial board piece business dimensions, promote a company industrial board considerably piece income, improve company estate structure thereby, maintain continuously gain ability.
Reporter of Chinese net finance and economics combs discovery, willow drug stock realized battalion to receive 9.45 billion yuan 2017, in Chinese traditional medicine manufacturing domain realizes battalion to receive 48 million yuan, occupy about than 0.5% ; Implementation battalion received 5.52 billion yuan first half of the year 2018, in Chinese traditional medicine manufacturing domain realizes battalion to receive 49 million yuan, occupy about than 0.9% .
"The big market nowadays is copy pharmacy, is not medium officinal. " Shi Lichen says, although the country is in,produce officinally, but get in moving process a lot of limitation, officinal value is being reduced in, the market anticipates and not ideal. "Quantity, policy grows officinally to give aid to in strength is far as copy pharmacy, willow drug stock ' lane turned over ' . In the meantime, the careless grain of money of medicine made of two or more ingredients of 10 thousand pharmacy mixes 10 thousand phlogistic health piece income is not much. The careless grain of money of medicine made of two or more ingredients of 10 thousand pharmacy mixes 10 thousand phlogistic health piece income is not much..
The data shows, careless grain of money of compound of product of dominant of 10 thousand pharmacy and 10 thousand phlogistic health piece (capsule) the patent product that is countrywide exclusive production, hold the main share of sales revenue of past years of 10 thousand pharmacy. 10 thousand pharmacy realized battalion to receive 120 million yuan 2017, net profit 66 million yuan; 1-8 month realized battalion to receive 98 million yuan 2018, net profit 51 million yuan.
